Abstracts published ahead of the 2025 American Society of Clinical Oncology Annual Meeting found persistent ovarian cancer ...

Twelve-year-old Maddie Muller, in remission from ovarian cancer, walked the runway to raise awareness and support research. Diagnosed at 8 with no symptoms, she now inspires others fighting the ...

Discussing ‘cure’ may risk oncologists’ credibility, should a patient’s ovarian cancer recur,” researchers wrote.

Tired of awareness campaigns that fade? Emily Campbell's "Not These Ovaries" sparks action for faster ovarian cancer ...

New research led by Irish scientists has uncovered how lipid-rich fluid in the abdomen, known as ascites, plays a central role in weakening the body's immune response in advanced ovarian cancer.

Ovarian cancer is one of those. Ovarian cancer starts in the ovaries, which are two small glands located on either side of ...

AbbVie's Elahere has been shown to reduce the risk of death in patients with folate receptor-alpha (FRα) positive, platinum-resistant ovarian cancer by a third, reinforcing its blockbuster ...

Ovarian cancer is an abnormal cell growth (tumour) arising in the ovary. The majority of ovarian cancers are epithelial and develop in women over 50. Screening is highly recommended in women with ...

A phase II open-label study of olutasidenib post-transplant maintenance therapy for patients with IDH1-mutated myeloid malignancies. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting ...

PYNNACLE phase 2 clinical trial of rezatapopt in patients with advanced solid tumors harboring a TP53 Y220C mutation. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...

Cervical, ovarian, endometrial, vulvar, and vaginal cancers represent a significant health challenge for women globally. Despite medical advancements ...